-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Constellium, Lowers Price Target to $35

Benzinga·07/08/2026 17:21:00
Listen to the news
UBS analyst Alex Stansbury maintains Constellium (NYSE:CSTM) with a Buy and lowers the price target from $38 to $35.